In trypanosomatids, trypanothione replaces glutathione in all glutathione-dependent processes. Of the two enzymes involved in the glyoxalase pathway, glyoxalase I and glyoxalase II, the latter shows absolute specificity towards trypanothione thioester, making this enzyme an excellent model to understand the molecular basis of trypanothione binding. Cloned glyoxalase II from Leishmania infantum was overexpressed in Escherichia coli, purified and crystallized. Crystals belong to space group C222(1) (unit-cell parameters a = 65.6, b = 88.3, c = 85.2 angstrom) and diffract beyond 2.15 angstrom using synchrotron radiation. The structure was solved by molecular replacement using the human glyoxalase II structure as a search model. These results, ...
Cysteine biosynthesis is a potential target for drug development against parasitic Leishmania specie...
Glyoxalase I and II form a ubiquitous glutathione-dependent pathway for the detoxification of reacti...
The glyoxalase system is a ubiquitous detoxification pathway that protects against cellular damage c...
Glyoxalase I GLO1 is the first of the two glyoxalase pathway enzymes. It catalyzes the formation ...
Trypanothione replaces glutathione in defence against cellular damage caused by oxidants, xenobiotic...
Glyoxalase I (GLO1) is a putative drug target for trypanosomatids, which are pathogenic protozoa tha...
Glyoxalase I forms part of the glyoxalase pathway that detoxifies reactive aldehydes such as methylg...
Glyoxalase I (GLO1) is a putative drug target for trypanosomatids, which are pathogenic protozoa tha...
The most promising targets for Leishmania-specific drug design are two key enzymes involved in the u...
AbstractBackground: NAD-dependent glycerol-3-phosphate dehydrogenase (GPDH) catalyzes the interconve...
The glyoxalase system, comprizing glyoxalase I and glyoxalase II, is a ubiquitous pathway that detox...
AbstractBackground: Glyoxalase II, the second of two enzymes in the glyoxalase system, is a thiolest...
BACKGROUND: NAD-dependent glycerol-3-phosphate dehydrogenase (GPDH) catalyzes the interconversion of...
Background: Glyoxalase I is a metalloenzyme of the glyoxalase pathway that plays a central role in e...
Trypanosomatids are pathogenic protozoa of the order Kinetoplastida. A unique feature of these paras...
Cysteine biosynthesis is a potential target for drug development against parasitic Leishmania specie...
Glyoxalase I and II form a ubiquitous glutathione-dependent pathway for the detoxification of reacti...
The glyoxalase system is a ubiquitous detoxification pathway that protects against cellular damage c...
Glyoxalase I GLO1 is the first of the two glyoxalase pathway enzymes. It catalyzes the formation ...
Trypanothione replaces glutathione in defence against cellular damage caused by oxidants, xenobiotic...
Glyoxalase I (GLO1) is a putative drug target for trypanosomatids, which are pathogenic protozoa tha...
Glyoxalase I forms part of the glyoxalase pathway that detoxifies reactive aldehydes such as methylg...
Glyoxalase I (GLO1) is a putative drug target for trypanosomatids, which are pathogenic protozoa tha...
The most promising targets for Leishmania-specific drug design are two key enzymes involved in the u...
AbstractBackground: NAD-dependent glycerol-3-phosphate dehydrogenase (GPDH) catalyzes the interconve...
The glyoxalase system, comprizing glyoxalase I and glyoxalase II, is a ubiquitous pathway that detox...
AbstractBackground: Glyoxalase II, the second of two enzymes in the glyoxalase system, is a thiolest...
BACKGROUND: NAD-dependent glycerol-3-phosphate dehydrogenase (GPDH) catalyzes the interconversion of...
Background: Glyoxalase I is a metalloenzyme of the glyoxalase pathway that plays a central role in e...
Trypanosomatids are pathogenic protozoa of the order Kinetoplastida. A unique feature of these paras...
Cysteine biosynthesis is a potential target for drug development against parasitic Leishmania specie...
Glyoxalase I and II form a ubiquitous glutathione-dependent pathway for the detoxification of reacti...
The glyoxalase system is a ubiquitous detoxification pathway that protects against cellular damage c...